Home ControlRad Inc.

ControlRad Inc.

    ControlRad™ Secures $15 Million Series B Financing

    The Series B round, which was led by Questa Capital, will be used for fueling the commercial launch of the innovative ControlRad Trace system.

    First Clinical Use of ControlRad Trace Radiation Reduction Technology

    The initial procedures were performed at Niagara Falls Memorial Medical Center, Niagara Falls, NY, by Andrew Cappuccino, M.D., an orthopedic surgeon specializing in minimally invasive spine surgery.

    ControlRad Announces FDA Clearance and Launch of the Only Radiation Reduction Technology that Integrates into Mobile C-arms

    The ControlRad Trace is the only technology that can be integrated into existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure.